167 related articles for article (PubMed ID: 18442812)
1. Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.
Liu T; Zhang M; Zhang H; Sun C; Yang X; Deng Y; Ji W
Eur J Pharmacol; 2008 Jun; 587(1-3):78-84. PubMed ID: 18442812
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
Liu T; Peng H; Zhang M; Deng Y; Wu Z
Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma.
Liu T; Zhang M; Zhang H; Sun C; Deng Y
Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1225-32. PubMed ID: 18309509
[TBL] [Abstract][Full Text] [Related]
4. [Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells].
Liu T; Zhang M; Deng Y; Zhang H; Sun C; Yang X; Ji W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(9):403-7. PubMed ID: 18652313
[TBL] [Abstract][Full Text] [Related]
5. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B.
Zhang M; Zhang H; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
Cancer Chemother Pharmacol; 2009 Mar; 63(4):635-42. PubMed ID: 18521604
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling.
Zhang M; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
Pancreas; 2010 Aug; 39(6):923-9. PubMed ID: 20182390
[TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
8. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.
Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S
Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP
Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
[TBL] [Abstract][Full Text] [Related]
11. Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.
Awasthi N; Schwarz MA; Schwarz RE
Cancer Chemother Pharmacol; 2011 Sep; 68(3):571-82. PubMed ID: 21110024
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer.
Kim HJ; Park JH; Kim JK
Chem Biol Interact; 2014 Aug; 219():1-8. PubMed ID: 24858077
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR
Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378
[TBL] [Abstract][Full Text] [Related]
14. Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2.
Jin ZQ; Hao J; Yang X; He JH; Liang J; Yuan JW; Mao Y; Liu D; Cao R; Wu XZ; Li X; Chen D
Oncol Rep; 2018 Oct; 40(4):2127-2136. PubMed ID: 30106443
[TBL] [Abstract][Full Text] [Related]
15. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibitory effect of Cucurbitacin E on breast cancer cells.
Lan T; Wang L; Xu Q; Liu W; Jin H; Mao W; Wang X; Wang X
Int J Clin Exp Pathol; 2013; 6(9):1799-805. PubMed ID: 24040444
[TBL] [Abstract][Full Text] [Related]
17. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B.
El-Senduny FF; Badria FA; El-Waseef AM; Chauhan SC; Halaweish F
Tumour Biol; 2016 Jan; 37(1):685-98. PubMed ID: 26242260
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: identification of intracellular thiols as critical targets.
Kausar H; Munagala R; Bansal SS; Aqil F; Vadhanam MV; Gupta RC
Cancer Lett; 2013 May; 332(1):35-45. PubMed ID: 23340170
[TBL] [Abstract][Full Text] [Related]
19. The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer.
Aribi A; Gery S; Lee DH; Thoennissen NH; Thoennissen GB; Alvarez R; Ho Q; Lee K; Doan NB; Chan KT; Toh M; Said JW; Koeffler HP
Int J Cancer; 2013 Jun; 132(12):2730-7. PubMed ID: 23165325
[TBL] [Abstract][Full Text] [Related]
20. ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY.
Wang WD; Liu Y; Su Y; Xiong XZ; Shang D; Xu JJ; Liu HJ
Afr J Tradit Complement Altern Med; 2017; 14(2):75-82. PubMed ID: 28573224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
